This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GIBBS, C. P.
Right arrow Articles by SIMON, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GIBBS, C. P.
Right arrow Articles by SIMON, M. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery 79:888-97 (1997)
© 1997 The Journal of Bone and Joint Surgery, Inc.

Oncological Outcomes of Operative Treatment of Subcutaneous Soft-Tissue Sarcomas of the Extremities*

C. PARKER GIBBS, M.D.{dagger}, TERRANCE D. PEABODY, M.D.{dagger}, ARNO J. MUNDT, M.D.{dagger}, ANTHONY G. MONTAG, M.D.{dagger} and MICHAEL A. SIMON, M.D.{dagger}, CHICAGO, ILLINOIS

Investigation performed at The University of Chicago Medical Center, Chicago

We reviewed the cases of sixty-two patients who had had a subcutaneous sarcoma to determine the effect of tumor and treatment-related variables on the rates of survival and local recurrence. Fifty-nine (95 per cent) of the patients had had an operation at another hospital before being referred to us. Twenty-nine (47 per cent) of the sixty-two tumors were high-grade, forty-two (68 per cent) were small (five centimeters or less), and thirty (48 per cent) were malignant fibrous histiocytomas. We followed a treatment strategy that consisted of repeat excision with the goal of obtaining wide margins. Excluding thirteen patients who had had a palpable local recurrence at the time of presentation, twenty (49 per cent) of forty-one patients who had had a marginal excision at another hospital had microscopic residual tumor on repeat excision. At a median of fifty-six months after the repeat excision, fifty (81 per cent) of the sixty-two patients had been continuously disease-free, one had no evidence of disease, eight had died of the disease, and three had died of other causes. The five-year rate of disease-free survival was 85 per cent (fifty-three of sixty-two patients). There were three local recurrences, all in patients who had had a marginal resection. No recurrences were noted in patients who had had a wide local excision of the tumor or of the previous operative field. Multivariate analysis revealed that a large tumor (greater than five centimeters), a marginal excision, and adjuvant radiation therapy were associated with a worse prognosis. Excellent rates of survival for patients who have a subcutaneous sarcoma, including those who have a large or high-grade tumor and those who have residual tumor following a previous operation, can be obtained with carefully planned operative treatment alone. We recommend operative excision or repeat excision with wide margins because of the high prevalence of residual tumor. Size is the most important tumor-related factor, and the operative margin is the most important treatment-related factor. The additional value of adjuvant radiation therapy remains unproved.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Foot & Ankle SpecialistHome page
H. DeGroot III
Approach to the Management of Soft Tissue Tumors of the Foot and Ankle
Foot & Ankle Specialist, June 1, 2008; 1(3): 168 - 176.
[Abstract] [PDF]


Home page
JBJSHome page
T. A. Damron, C. P. Beauchamp, B. T. Rougraff, and W. G. Ward
Soft-Tissue Lumps and Bumps
J. Bone Joint Surg. Am., May 28, 2003; 85(6): 1142 - 1155.
[Full Text] [PDF]


Home page
JCOHome page
E. H. Baldini, J. Goldberg, C. Jenner, J. B. Manola, G. D. Demetri, C. D.M. Fletcher, and S. Singer
Long-Term Outcomes After Function-Sparing Surgery Without Radiotherapy for Soft Tissue Sarcoma of the Extremities and Trunk
J. Clin. Oncol., October 1, 1999; 17(10): 3252 - 3259.
[Abstract] [Full Text] [PDF]